Innovation is one of the strategic and fundamental Biokit pillars 

Biokit innovates at all levels: with regard to biomaterials, assays, and manufacturing biotechnology processes.

Open innovation is not a new concept for Biokit; from the 80s onwards Biokit has been collaborating with prestigious universities, research centres and companies around the world to constantly offer the most advanced solutions.

Innovation in Assays


Assay Innovation includes design of prototypes and Proof-of-Concept evaluation to verify biomaterials and reagent formulation for new immunoassays.

INNOVATION in biotechnology


Technology Innovation includes Products and Process Biotechnology activities for enhanced assay performance (sensitivity, specificity, stability) and for enhanced assay manufacturing processes (high yield, high scalability, robust production of antigens and antibodies).